KMTS (kestramedical.com) צמיחת רווחים בשנה הנוכחית

Kestra Medical Technologies develops compact defibrillators for 24/7 patient cardiac protection. The YoY net income per share growth rate demonstrates current dynamics, where the value -0.80 reflects the metric's balance. Kestra Medical Technologies is implementing AI monitoring for autonomous rhythm control, while the high complexity of FDA certification provides a robust moat for its market niche against competitors.

This indicator calculates the year-over-year earnings per share (EPS) growth, reflecting the efficiency of net income generation for shareholders relative to the previous period. A stable annual growth rate in net income per share confirms the resilience of Kestra Medical Technologies (KMTS) to macroeconomic shocks, as demand for cardiology equipment is not subject to cyclicality or seasonal fluctuations.